S100A family is a group of immune markers associated with poor prognosis and immune cell infiltration in hepatocellular carcinoma
Abstract Background Hepatocellular carcinoma (HCC) is one of the most common human cancers with poor prognosis in the world. HCC has become the second leading cause of cancer-related death in China. It is urgent to identify novel biomarker and valid target to effectively diagnose, treat or predict t...
Main Authors: | Yuchen Qi, Yujing Zhang, Jianwen Li, Mengting Cai, Bo Zhang, Zhangtao Yu, Yuhang Li, Junkai Huang, Xu Chen, Yinghui Song, Sulai Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-07-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-023-11127-3 |
Similar Items
-
A pilot study of S100A4, S100A8/A9, and S100A12 in dilated cardiomyopathy: novel biomarkers for diagnosis or prognosis?
by: Ying Yu, et al.
Published: (2024-02-01) -
Increased plasma levels of S100A8, S100A9, and S100A12 in chronic spontaneous urticaria
by: Qiong-Yan Zhou, et al.
Published: (2019-01-01) -
Increased Serum Levels of S100A4 and S100A15 in Individuals Suffering from Hidradenitis Suppurativa
by: Aleksandra Batycka-Baran, et al.
Published: (2021-11-01) -
A proteome-wide screen identifies the calcium binding proteins, S100A8/S100A9, as clinically relevant therapeutic targets in aortic dissection
by: Hui Jiang, et al.
Published: (2024-01-01) -
Serum alarmin S100A8/S100A9 levels and its potential role as biomarker in myocarditis
by: Irene Müller, et al.
Published: (2020-08-01)